Watch our recorded presentation on metabolomic characterization at BPI US West 2026. Erin Weisenhorn, Senior Scientist II, Mass Spectrometry at Just – Evotec Biologics, discussed how deep metabolic insights translate into higher viability and more robust upstream runs.

You’ll hear:

• What to monitor in CHO perfusion to protect viability and yield
• Where metabolomics (incl. ML enabled quantitation) fits in real workflows
• A media optimization case study showing improved day 14 viability in a perfusion context